Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 856

1.

A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.

Yan L, Siddiqui AA, Laique SN, Saumoy M, Kahaleh M, Yoo J, Kalra A, Mathew A, Sterling J, Rao R, Lieberman M, Cosgrove N, Sharaiha RZ.

Minerva Gastroenterol Dietol. 2017 Mar;63(1):50-54. doi: 10.23736/S1121-421X.16.02341-2. Epub 2016 Nov 8.

PMID:
27824244
2.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

3.

Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, Chari ST, Farnell MB.

Arch Surg. 2008 Jul;143(7):639-46; discussion 646. doi: 10.1001/archsurg.143.7.639.

PMID:
18645105
4.

[Limited pancreatic resections for intraductal papillary mucinous neoplasm].

Blanc B, Sauvanet A, Couvelard A, Pessaux P, Dokmak S, Vullierme MP, Lévy P, Ruszniewski P, Belghiti J.

J Chir (Paris). 2008 Nov-Dec;145(6):568-78. French.

PMID:
19106888
5.

Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.

Attiyeh MA, Fernández-Del Castillo C, Al Efishat M, Eaton AA, Gönen M, Batts R, Pergolini I, Rezaee N, Lillemoe KD, Ferrone CR, Mino-Kenudson M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Wolfgang CL, Allen PJ.

Ann Surg. 2018 Jan;267(1):157-163. doi: 10.1097/SLA.0000000000002015.

6.

Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.

Tang RS, Weinberg B, Dawson DW, Reber H, Hines OJ, Tomlinson JS, Chaudhari V, Raman S, Farrell JJ.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):815-9; quiz 719. doi: 10.1016/j.cgh.2008.04.005.

PMID:
18602036
7.

Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kobayashi S, Kojima M, Miyauchi H, Asano T.

J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):798-802. doi: 10.1007/s00534-009-0173-8. Epub 2009 Aug 29.

PMID:
19727540
8.

Patterns of Recurrence After Resection of IPMN: Who, When, and How?

Marchegiani G, Mino-Kenudson M, Ferrone CR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, Castillo CF.

Ann Surg. 2015 Dec;262(6):1108-14. doi: 10.1097/SLA.0000000000001008.

PMID:
25793719
9.

Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.

Kang MJ, Jang JY, Lee KB, Chang YR, Kwon W, Kim SW.

Ann Surg. 2014 Aug;260(2):356-63. doi: 10.1097/SLA.0000000000000470.

PMID:
24378847
10.

Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.

Yogi T, Hijioka S, Imaoka H, Mizuno N, Hara K, Tajika M, Tanaka T, Ishihara M, Shimizu Y, Hosoda W, Yatabe Y, Niwa Y, Yoshimura K, Bhatia V, Fujita J, Yamao K.

J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):757-65. doi: 10.1002/jhbp.280. Epub 2015 Aug 3. Erratum in: J Hepatobiliary Pancreat Sci. 2017 Jan;24(1):72-73.

PMID:
26148131
11.

The distance of tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm: where to resect and how to predict it.

Okada K, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, Dowaki S, Tobita K, Ohtani Y, Kawaguchi Y, Tanaka M, Inokuchi S, Makuuchi H.

J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):516-22. doi: 10.1007/s00534-009-0257-5. Epub 2010 Feb 3.

PMID:
20714841
12.

Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.

Passot G, Lebeau R, Hervieu V, Ponchon T, Pilleul F, Adham M.

Pancreas. 2012 Jan;41(1):137-41. doi: 10.1097/MPA.0b013e318222bc9c.

PMID:
22076564
13.

Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.

Pea A, Yu J, Rezaee N, Luchini C, He J, Dal Molin M, Griffin JF, Fedor H, Fesharakizadeh S, Salvia R, Weiss MJ, Bassi C, Cameron JL, Zheng L, Scarpa A, Hruban RH, Lennon AM, Goggins M, Wolfgang CL, Wood LD.

Ann Surg. 2017 Jul;266(1):133-141. doi: 10.1097/SLA.0000000000001817.

14.

Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.

Correa-Gallego C, Do R, Lafemina J, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ.

Ann Surg Oncol. 2013 Dec;20(13):4348-55. doi: 10.1245/s10434-013-3207-z. Epub 2013 Sep 18.

PMID:
24046103
15.

Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.

Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM.

Surgery. 2015 Oct;158(4):937-44; discussion 944-5. doi: 10.1016/j.surg.2015.06.003. Epub 2015 Jul 11.

PMID:
26173683
16.
17.

Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.

Yang AD, Melstrom LG, Bentrem DJ, Ujiki MB, Wayne JD, Strouch M, Bell RH, Rao SM, Talamonti MS.

Surgery. 2007 Oct;142(4):529-34; discussion 534-7.

PMID:
17950345
18.

Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.

Fritz S, Klauss M, Bergmann F, Strobel O, Schneider L, Werner J, Hackert T, Büchler MW.

Ann Surg. 2014 Nov;260(5):848-55; discussion 855-6. doi: 10.1097/SLA.0000000000000980.

PMID:
25379856
19.

MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.

Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H.

Pancreatology. 2013 Nov-Dec;13(6):583-8. doi: 10.1016/j.pan.2013.08.007. Epub 2013 Aug 30.

PMID:
24280573
20.

Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, Clain JE, Norton IA, Pearson RK, Petersen BT, Wiersema MJ, Farnell MB, Sarr MG.

Gastroenterology. 2002 Nov;123(5):1500-7.

PMID:
12404225

Supplemental Content

Support Center